AUTHOR=Padilla-Rivas Gerardo R. , Delgado-Gallegos Juan Luis , Garza-Treviño Gerardo , Galan-Huerta Kame A. , G-Buentello Zuca , Roacho-Pérez Jorge A. , Santoyo-Suarez Michelle Giovana , Franco-Villareal Hector , Leyva-Lopez Ahidée , Estrada-Rodriguez Ana E. , Moreno-Cuevas Jorge E. , Ramos-Jimenez Javier , Rivas-Estrilla Ana M. , Garza-Treviño Elsa N. , Islas Jose Francisco TITLE=Association between mortality and cardiovascular diseases in the vulnerable Mexican population: A cross-sectional retrospective study of the COVID-19 pandemic JOURNAL=Frontiers in Public Health VOLUME=10 YEAR=2022 URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.1008565 DOI=10.3389/fpubh.2022.1008565 ISSN=2296-2565 ABSTRACT=

Cardiovascular diseases (CVDs) continue to be the leading cause of death worldwide. Over the past couple of years and with the surge of the COVID-19 pandemic, mortality from CVDs has been slightly overshadowed by those due to COVID-19, although it was during the peak of the pandemic. In the present study, patients with CVDs (CVDs; n = 41,883) were analyzed to determine which comorbidities had the largest impact on overall patient mortality due to their association with both diseases (n = 3,637). Obesity, hypertension, and diabetes worsen health in patients diagnosed positive for COVID-19. Hence, they were included in the overview of all patients with CVD. Our findings showed that 1,697 deaths were attributable to diabetes (p < 0.001) and 987 deaths to obesity (p < 0.001). Lastly, 2,499 deaths were attributable to hypertension (p < 0.001). Using logistic regression modeling, we found that diabetes (OR: 1.744, p < 0.001) and hypertension (OR: 2.179, p < 0.001) significantly affected the mortality rate of patients. Hence, having a CVD diagnosis, with hypertension and/or diabetes, seems to increase the likelihood of complications, leading to death in patients diagnosed positive for COVID-19.